What Percentage of Carotid Artery Blockage Requires Surgery?

Discover the key considerations for carotid artery blockage surgery, including specific percentage thresholds and diagnostic approaches. Learn about treatment decisions and management.

For people who have had stroke symptoms, surgery is generally recommended when the internal carotid artery is blocked by 70 percent or more, and it may be considered at 50 to 69 percent depending on clinical factors. For people without symptoms, the threshold drops to around 60 percent. But these percentages, while widely quoted, are only part of the decision. How the blockage is measured, what the plaque looks like on imaging, and how well modern medications are working for a given patient all feed into whether a surgeon recommends an operation.

The Threshold for People With Symptoms

The clearest evidence for surgery comes from patients who have already experienced a warning sign: a transient ischemic attack (a brief episode of stroke-like symptoms that resolves) or a minor stroke. In these patients, a blockage of 70 percent or more in the internal carotid artery carries the highest risk of a major stroke, and that risk is greatest within the first 48 hours after the initial event. The landmark European Carotid Surgery Trial showed just how stark the difference is at this level: among patients with 70 to 99 percent stenosis, those assigned to surgery had a roughly sixfold lower rate of stroke on the affected side over the following three years compared with those treated medically.

At 50 to 69 percent stenosis, the picture gets murkier. Surgery is considered “acceptable but not proven” in this range for symptomatic patients, according to American Heart Association consensus guidelines. Whether it makes sense depends on specifics like the patient’s age, overall health, and whether the surgeon’s complication rate is low enough to justify the procedure. Below 50 percent stenosis in symptomatic patients, surgery does not help. The risk of the operation itself outweighs whatever protection it might offer.

The Threshold When There Are No Symptoms

Many people discover they have carotid artery narrowing incidentally, during a routine exam or an imaging study done for another reason. For these asymptomatic patients, guidelines suggest considering surgery starting at around 60 percent stenosis. A systematic review of 28 guidelines worldwide found that the vast majority endorsed carotid endarterectomy for asymptomatic stenosis in the range of roughly 50 to 99 percent in patients at average surgical risk.

But here is where the field is genuinely divided. Those thresholds were established decades ago, when medications for blood pressure, cholesterol, and blood clotting were less effective. With today’s best medical therapy, the annual risk of stroke in asymptomatic patients has dropped to about half a percent per year. That is a big change, and it means the absolute benefit of surgery in asymptomatic patients is narrower than it was when the original trials were run. Many vascular specialists now argue that most asymptomatic patients can be managed with medications alone, reserving surgery for those whose plaque looks particularly unstable or whose stenosis is progressing rapidly.

Why the Percentage Itself Can Be Misleading

One detail that trips up almost everyone outside of vascular medicine is that a “70 percent blockage” does not mean the same thing everywhere. Two different measurement systems, both widely used, will assign different percentages to the exact same narrowing. The North American method (called NASCET) compares the narrowest point of the blockage to the normal artery beyond it, while the European method (called ECST) compares the narrowest point to the estimated original width of the artery at the site of the plaque. Because the artery naturally bulges at the carotid bifurcation, the European method always produces a higher number for the same physical narrowing.

The practical difference is not trivial. A blockage graded as 70 percent by the North American method corresponds to roughly 83 percent under the European method. In one large comparison of over 1,000 angiograms, the two methods disagreed on whether a narrowing was mild, moderate, or severe in more than half of all measurements. Most surgical guidelines today reference the North American system, so when your doctor says “70 percent,” you should know which scale they are using. If the measurement comes from a European institution or an older report, the number could mean something quite different in terms of actual lumen narrowing.

Ultrasound Variability Adds Another Layer

Most people first learn about a carotid blockage from a duplex ultrasound, a painless scan that estimates the degree of narrowing by measuring how fast blood flows through it. Faster flow at the narrowed point means a tighter blockage. Ultrasound is highly accurate for detecting severe stenosis of 70 percent or more, with a study reporting sensitivity above 90 percent and specificity above 93 percent when using a peak velocity threshold of 200 centimeters per second.

The problem is that ultrasound labs across the United States do not all use the same velocity thresholds to classify a blockage as moderate or severe. A national survey found 60 distinct velocity cutoffs in use. The threshold for calling a blockage “moderate” (50 percent or more) ranged from 110 to 245 centimeters per second, and the threshold for “severe” (70 percent or more) ranged from 175 to 340 centimeters per second. That means the same patient could be told they have a 65 percent blockage at one lab and a 75 percent blockage at another, purely because of how each lab calibrates its equipment and interprets velocity data. If a treatment decision hinges on whether you are above or below 70 percent, this kind of variability matters. It is one reason that borderline cases often go on to get a CT angiogram or MR angiogram for confirmation before surgery is scheduled.

What the Plaque Looks Like Matters Too

Percentage of narrowing was the only metric available when the landmark surgery trials were designed. Since then, imaging technology has revealed that what the plaque is made of can be as important as how much space it takes up. A stable, densely calcified plaque that narrows the artery by 75 percent may actually pose less danger than a soft, lipid-rich plaque at 55 percent with a thin fibrous cap ready to rupture.

Specific features visible on MRI and CT scanning are now known to predict future stroke risk independently of the degree of narrowing. These include intraplaque hemorrhage (bleeding inside the plaque itself), a large lipid-rich necrotic core, and a thinning or ruptured fibrous cap. One prospective study followed patients for about five years and found that the presence of intraplaque hemorrhage roughly doubled the risk of a recurrent stroke or TIA on the same side, and that adding plaque imaging data to standard risk scores substantially improved the ability to predict who would have a future event. This is increasingly shaping clinical decisions: a patient with asymptomatic stenosis of 60 to 70 percent and a plaque full of hemorrhage or necrotic lipid may be pushed toward surgery, while a patient at the same percentage with a stable-looking plaque may safely continue with medications.

Modern Medical Therapy and the Shrinking Surgical Advantage

The original carotid surgery trials from the 1990s compared the operation against what was then considered “best medical therapy,” which by today’s standards was fairly basic. Since then, statins, tighter blood pressure targets, and improved antiplatelet regimens have dramatically changed the equation. In one major trial, high-dose statin therapy reduced fatal and non-fatal strokes by about a third in patients with a recent stroke or TIA, and cut cardiovascular events overall by roughly 42 percent.

This improvement in medical therapy is the main reason the debate over asymptomatic surgery has intensified. If medications alone can keep the annual stroke risk below one percent, the incremental benefit of an operation that itself carries a small but real risk of stroke, heart attack, or death becomes harder to justify across the board. Most specialists now agree that regardless of whether surgery is planned, every patient with carotid stenosis should be on intensive medical management: a high-potency statin, well-controlled blood pressure, antiplatelet medication, and lifestyle modifications like smoking cessation.

Endarterectomy Versus Stenting

When surgery is indicated, two main procedures exist. Carotid endarterectomy (CEA) is the traditional open operation: a surgeon makes an incision in the neck, opens the artery, and physically removes the plaque. Carotid artery stenting (CAS) is a minimally invasive alternative where a catheter is threaded through a blood vessel, usually from the groin, and a small mesh tube is placed inside the artery to hold it open.

Both procedures are effective, but the risk profiles differ in ways that matter by age. A Cochrane review of randomized trials found that in symptomatic patients, stenting carried a higher periprocedural risk of death or stroke compared to endarterectomy. That difference was concentrated in patients 70 and older, where the odds of a periprocedural stroke or death with stenting were roughly double those with open surgery. On the other hand, stenting is associated with fewer heart attacks in the perioperative period, an advantage that matters for patients with significant cardiac disease. The CREST trial, one of the largest head-to-head comparisons, concluded that the two approaches were broadly equivalent when patient age, anatomy, and operator experience were factored in.

A newer technique called transcarotid artery revascularization, or TCAR, is gaining ground. Rather than threading a catheter up from the groin through the aortic arch, the surgeon accesses the carotid artery directly through a small incision in the neck and places a stent while temporarily reversing blood flow to catch any debris before it reaches the brain. Early data suggest TCAR may carry a lower risk of the hyperperfusion complications that sometimes follow conventional stenting from the groin, though it is still similar to endarterectomy in most other outcome measures.

When the Artery Is Nearly Shut

You might assume that a 95 or 99 percent blockage would be the most urgent case for surgery, but near-occlusion is actually a paradox in carotid disease. When the artery is almost completely blocked, the brain has often already developed alternative blood supply routes through collateral vessels. The original NASCET trial found that surgery did not clearly benefit near-occlusion patients as much as it did those at 70 to 94 percent, and for years the standard advice was to manage them medically.

More recent meta-analyses have pushed back on that thinking. One pooled analysis found that the annual stroke rate was considerably higher under medical therapy alone compared to either endarterectomy or stenting. The one-year stroke- or death-free survival rate was about 96 percent after endarterectomy, 94 percent after stenting, and only 81 percent with medications alone. Another meta-analysis found stroke incidence rates per 100 patient-years were roughly three times higher in medically treated near-occlusion patients compared with those who had surgery or stenting. The evidence is still debated, but the trend is toward reconsidering intervention for these patients rather than defaulting to medical therapy alone.

How Quickly Should Surgery Happen After Symptoms

Timing is its own variable. When someone has a TIA or minor stroke with a significant carotid blockage behind it, there used to be a tendency to wait a few weeks before operating, out of concern that operating on freshly injured brain tissue might increase the surgical risk. A systematic review of studies on timing put that concern largely to rest, finding that surgery within the first week in neurologically stable patients was not associated with a meaningfully higher complication rate than delayed surgery. Because the risk of a recurrent stroke is highest in the first 48 hours after a warning event, current practice favors urgent evaluation and early intervention when feasible.

Should You Be Screened If You Have No Symptoms

Given all this discussion of thresholds and surgery, you might wonder whether everyone should get their carotid arteries checked. The U.S. Preventive Services Task Force explicitly recommends against screening for carotid artery stenosis in the general adult population. The reasoning is that in people who have never had symptoms, the chance of finding a blockage that genuinely needs intervention is low, while the risk of false positives leading to unnecessary procedures is real. Those mobile screening vans you see advertised at health fairs are not backed by the evidence for routine use in people at average risk.

Screening may make more sense in people with multiple risk factors for atherosclerosis, a history of radiation to the neck, or an audible bruit heard with a stethoscope. But even then, the finding of a blockage does not automatically lead to surgery. It leads to a conversation about whether the blockage, the plaque characteristics, and the patient’s overall risk profile add up to a situation where intervention would reduce harm rather than add to it.

What Happens After Surgery

Recurrent narrowing at the surgical site is a real phenomenon. In one prospective randomized trial comparing different closure techniques after endarterectomy, about 10 to 46 percent of patients developed some degree of restenosis depending on the method used, though the majority of these narrowings were modest. Importantly, none of the recurrent blockages that reached 80 percent or higher regressed on their own, while more than a third of moderate recurrent narrowings (those between 20 and 80 percent) resolved over time, particularly when the surgeon had used a patch to close the artery rather than stitching it directly. Routine follow-up ultrasound after the procedure is standard practice to catch any clinically significant recurrence early.

One uncommon but serious complication to be aware of is cerebral hyperperfusion syndrome, which happens when a brain accustomed to reduced blood flow suddenly receives normal flow after the blockage is removed. It can cause severe headache, seizures, and in rare cases, brain hemorrhage. A large database study found this occurs in about a quarter of one percent of procedures overall, with conventional groin-based stenting carrying the highest risk at roughly three times the rate seen after endarterectomy. Tight blood pressure control in the days after the procedure is the main preventive strategy.